HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Online-Only Appendix All Versions of this Article: dc07-0147v1 30/8/2086    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaidya, D. Articles by Ouyang, P. Search for Related Content PubMed PubMed Citation Articles by Vaidya, D. Articles by Ouyang, P. Social Bookmarking                What's this?

Defining the Metabolic Syndrome Construct: Multi-Ethnic Study of Atherosclerosis Cross-sectional Analysis

Johns Hopkins University¹,
Northwestern University²,
University of Minnesota³,
Wake Forest University⁴

dvaidya1{at}jhmi.edu

ABSTRACT

Objective:It is controversial if the clustering of certain metabolic abnormalities should be separately designated as the metabolic syndrome (MetSyn). We operationalized the "syndrome" concept and tested whether MetSyn was compatible with these operational constructs.

Research Design and Methods:The baseline cross section of the Multi-Ethnic Study of Atherosclerosis recruited a population-based cohort of 6781 persons, aged 45-84 years, from 6 communities in the United States. MetSyn components (waist circumference, blood pressure, fasting serum HDL-cholesterol, triglycerides, plasma glucose), HOMA insulin resistance (fasting glucosexinsulin) and intimal-medial thickness (IMT) in the common and internal carotid arteries by B-mode ultrasound were measured.

Results:1. Higher syndrome component count is associated with higher HOMA levels (trend p < 0.001). 2. Given the prevalence of individual components, the non-prevalence of any component or the co-prevalence of 4 or 5 components is greater than expected (² p<0.001). 3. After accounting for the additive association of each component, the current definition of MetSyn (co-prevalence of 3 or more components) does not have supra-additive association with thicker IMT in the common carotid (men: p = 0.075, women p = 0.949) or internal carotid artery (men: p = 0.106, women: p = 0.121).

Conclusions:1. MetSyn did not have supra-additive association with IMT, but 2. its components clustered greater than chance expectation and 3. higher component count was associated with greater insulin resistance. MetSyn was compatible with two of three "syndrome" constructs tested.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K G M M Alberti and P Z Zimmet Should we dump the metabolic syndrome? No BMJ, March 22, 2008; 336(7645): 641 - 641. [Full Text] [PDF]